CUSIP 492327101COMKROSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
164 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 2.29M | $46.64M | −426.6K | Reduced |
| 2 | Vanguard Group Inc | 1.53M | $31.06M | −1.19M | Reduced |
| 3 | Arrowstreet Capital, Limited Partnership | 1.33M | $27.17M | +1.08M | Added |
| 4 | State Street Corp | 1.08M | $21.91M |
| −227.0K |
| Reduced |
| 5 | Madison Avenue Partners, LP | 823.7K | $16.77M | −1.88M | Reduced |
| 6 | Orbimed Advisors LLC | 804.2K | $16.37M | −214.5K | Reduced |
| 7 | Qube Research & Technologies Ltd | 783.9K | $15.96M | +480.8K | Added |
| 8 | Jacobs Levy Equity Management, Inc | 768.4K | $15.65M | +161.3K | Added |
| 9 | D. E. Shaw & Co., Inc. | 755.5K | $15.38M | −576.0K | Reduced |
| 10 | Federated Hermes, Inc. | 654.7K | $13.33M | +140.6K | Added |
See every fund holding Keros Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders